Clinical trial
TAXUS PERSEUS Workhorse
NCT00484315 · Boston Scientific Corporation, Industry · Completed
Key facts
| NCT number | NCT00484315 |
|---|---|
| Title | TAXUS PERSEUS Workhorse |
| Official title | A Prospective Evaluation in a Randomized Trial of the Safety and Efficacy of the Use of the TAXUS Element Paclitaxel-Eluting Coronary Stent System for the Treatment of De Novo Coronary Artery Lesions |
| Acronym | PERSEUS WH |
| Lead sponsor | Boston Scientific Corporation, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Coronary Artery Disease |
| Intervention type | Device |
| Interventions | Percutaneous coronary intervention (PCI) with paclitaxel-eluting stent (TAXUS Element) implantation, Percutaneous coronary intervention (PCI) with paclitaxel-eluting stent (TAXUS Express) placement |
| Enrollment | 1,264 |
| Start date | Jul 1, 2007 |
| Primary completion | Sep 1, 2009 |
| Completion | Oct 1, 2013 |
| First posted | Jun 8, 2007 |
| Last update posted | May 8, 2014 |
| Countries | Australia, New Zealand, Singapore, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: